Top

Published in:

Open Access 01-10-2018 | Review

Aspects of Modern Biobank Activity – Comprehensive Review

Authors: Wiktor Paskal, Adriana M. Paskal, Tomasz Dębski, Maciej Gryziak, Janusz Jaworowski

Published in: Pathology & Oncology Research | Issue 4/2018

Abstract

Biobanks play an increasing role in contemporary research projects. These units meet all requirements to regard them as a one of the most innovative and up-to-date in the field of biomedical research. They enable conducting wide-scale research by the professional collection of biological specimens and correlated clinical data. Pathology units may be perceived roots of biobanking. The review aims at describing the concept of biobanks, their model of function and scientific potential. It comprises the division of biobanks, sample preservation methods and IT solutions as well as guidelines and recommendations for management of a vast number of biological samples and clinical data. Therefore, appropriate standard operating procedures and protocols are outlined. Constant individualization of diagnostic process and treatment procedures creates the niche for translational units. Thus, the role of biobanks in personalized medicine was also specified. The exceptionality of biobanks poses some new ethical-legal issues which have various solutions, in each legal system, amongst the world. Finally, distribution and activity of European biobanks are mentioned.

Fransson MN, Rial-Sebbag E, Brochhausen M, Litton JE (2015) Toward a common language for biobanking. Eur J Hum Genet 23. https://doi.org/10.1038/ejhg.2014.45

Kang B, Park J, Cho S, Lee M, Kim N, Min H et al (2013) Current status, challenges, policies, and bioethics of biobanks. Genomics inform 11(4):211–217. https://doi.org/10.5808/GI.2013.11.4.211 CrossRefPubMedPubMedCentral

Sak J, Pawlikowski J, Goniewicz M, Witt M (2012) Population biobanking in selected European countries and proposed model for a Polish national DNA bank. J Appl Genet 53(2):159–165. https://doi.org/10.1007/s13353-012-0082-4 CrossRefPubMedPubMedCentral

Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P, Marble Arch International Working Group on Biobanking for Biomedical R (2008) Biobanking for better healthcare. Mol Oncol 2(3):213–222. https://doi.org/10.1016/j.molonc.2008.07.004 CrossRefPubMedPubMedCentral

Goebell PJ, Morente MM (2010) New concepts of biobanks--strategic chance for uro-oncology. Urol Oncol 28(4):449–457. https://doi.org/10.1016/j.urolonc.2010.03.012 CrossRefPubMed

Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genom Proteomics 6(3):193–201. https://doi.org/10.1093/bfgp/elm023 CrossRef

Swede H, Stone CL, Norwood AR (2007) National population-based biobanks for genetic research. Genet Med 9(3):141–149. https://doi.org/10.1097/GIM.0b013e3180330039 CrossRefPubMed

Leitsalu L, Haller T, Esko T, Tammesoo ML, Alavere H, Snieder H et al (2014) Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. https://doi.org/10.1093/ije/dyt268

Zawati M, Borry P, Howard H (2011) Closure of population biobanks and direct-to-consumer genetic testing companies. Hum Genet 130(3):425–432. https://doi.org/10.1007/s00439-011-1019-4 CrossRefPubMed

10.

Awadalla P, Boileau C, Payette Y, Idaghdour Y, Goulet JP, Knoppers B et al. (2013) Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int J Epidemiol 42 (5):1285–1299. https://doi.org/10.1093/ije/dys160

11.

Andersson K, Bray F, Arbyn M, Storm H, Zanetti R, Hallmans G et al (2010) The interface of population-based cancer registries and biobanks in etiological and clinical research--current and future perspectives. Acta Oncol 49(8):1227–1234. https://doi.org/10.3109/0284186X.2010.496792 CrossRefPubMed

12.

Fannin M, Kent J (2015) Origin stories from a regional placenta tissue collection. New Genet Soc 34(1):25–51. https://doi.org/10.1080/14636778.2014.999153 CrossRefPubMedPubMedCentral

13.

Bonnelykke K, Sleiman P, Nielsen K, Kreiner-Moller E, Mercader JM, Belgrave D et al (2014) A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 46(1):51–55. https://doi.org/10.1038/ng.2830 CrossRefPubMed

14.

Haukkala A, Kujala E, Alha P, Salomaa V, Koskinen S, Swan H et al (2013) The return of unexpected research results in a biobank study and referral to health care for heritable long QT syndrome. Public Health Genomics 16(5):241–250. https://doi.org/10.1159/000354105 CrossRefPubMed

15.

Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S et al (2014) Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 46(11):1173–1186. https://doi.org/10.1038/ng.3097 http://www.nature.com/ng/journal/v46/n11/abs/ng.3097.html#supplementary-information CrossRefPubMedPubMedCentral

16.

Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T et al (2014) Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol 65(6):1069–1075. https://doi.org/10.1016/j.eururo.2013.12.058 CrossRefPubMedPubMedCentral

17.

Nieuwenhuijsen MJ, Smith R, Golfinopoulos S, Best N, Bennett J, Aggazzotti G et al. (2009) Health impacts of long-term exposure to disinfection by-products in drinking water in Europe: HIWATE. J Water Health 7 (2):185–18207. https://doi.org/10.2166/wh.2009.073

18.

Jeong CH, Wagner ED, Siebert VR, Anduri S, Richardson SD, Daiber EJ et al (2012) Occurrence and toxicity of disinfection byproducts in European drinking waters in relation with the HIWATE epidemiology study. Environ Sci Technol 46(21):12120–12128. https://doi.org/10.1021/es3024226 CrossRefPubMedPubMedCentral

19.

McKenzie F, Ferrari P, Freisling H, Chajes V, Rinaldi S, de Batlle J et al (2014) Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer. https://doi.org/10.1002/ijc.29315

20.

Engeset D, Braaten T, Teucher B, Kuhn T, Bueno-de-Mesquita HB, Leenders M et al (2014) Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Eur J Epidemiol. https://doi.org/10.1007/s10654-014-9966-4

21.

Ose J, Fortner RT, Schock H, Peeters PH, Onland-Moret NC, Bueno-de-Mesquita HB et al (2014) Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br J Cancer. https://doi.org/10.1038/bjc.2014.566

22.

Reza M, Cox D, Phillips L, Johnson D, Manoharan V, Grieves M et al (2017) MRC centre neuromuscular biobank (newcastle and london): supporting and facilitating rare and neuromuscular disease research worldwide. Neuromuscul Disord. https://doi.org/10.1016/j.nmd.2017.07.001

23.

De Souza YG, Greenspan JS (2013) Biobanking past, present and future: responsibilities and benefits. AIDS (London, England) 27(3):303–312. https://doi.org/10.1097/QAD.0b013e32835c1244 CrossRef

24.

Check Hayden E (2015) Proposed Ebola biobank would strengthen African science. Nature 524(7564):146–147. https://doi.org/10.1038/524146a CrossRefPubMed

25.

Hutchinson E (2014) Towards individualized cancer therapy: Challenges and prospects. Mol Oncol 8(1):1–8. https://doi.org/10.1016/j.molonc.2013.12.008 CrossRef

26.

Guerin JS, Murray DW, McGrath MM, Yuille MA, McPartlin JM, Doran PP (2010) Molecular medicine ireland guidelines for standardized biobanking. Biopreserv Biobank 8(1):3–63. https://doi.org/10.1089/bio.2010.8101 CrossRefPubMed

27.

Mohamadkhani A, Poustchi H (2015) Repository of Human Blood Derivative Biospecimens in Biobank: Technical Implications. Middle East J Dig Dis 7(2):61–68PubMedPubMedCentral

28.

Shabihkhani M, Lucey GM, Wei B, Mareninov S, Lou JJ, Vinters HV et al (2014) The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem 47(4–5):258–266. https://doi.org/10.1016/j.clinbiochem.2014.01.002 CrossRefPubMedPubMedCentral

29.

Duale N, Lipkin WI, Briese T, Aarem J, Ronningen KS, Aas KK et al (2014) Long-term storage of blood RNA collected in RNA stabilizing Tempus tubes in a large biobank--evaluation of RNA quality and stability. BMC Res Notes 7:633. https://doi.org/10.1186/1756-0500-7-633 CrossRefPubMedPubMedCentral

30.

King MJ, Garcon L, Hoyer JD, Iolascon A, Picard V, Stewart G et al (2015) ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 37(3):304–325. https://doi.org/10.1111/ijlh.12335 CrossRefPubMed

31.

Maimuna Mendy EC, Lawlor RT, Wright J, Wild CP (2017) Common minimum technical standards and protocols for biobanks dedicated to cancer research. Int Agency Res Cancer

32.

Higdon LE, Lee K, Tang Q, Maltzman JS (2016) Virtual Global Transplant Laboratory Standard Operating Procedures for Blood Collection, PBMC Isolation, and Storage. Transplantat Direct 2(9):e101. https://doi.org/10.1097/txd.0000000000000613 CrossRef

33.

Qin J, Alt JR, Hunsley BA, Williams TL, Fernando MR (2014) Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent. Cancer Cell Int 14(1):23. https://doi.org/10.1186/1475-2867-14-23 CrossRefPubMedPubMedCentral

34.

Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B et al (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13(3):920–928. https://doi.org/10.1158/1078-0432.ccr-06-1695 CrossRefPubMed

35.

Oxnard GR, Paweletz CP, Sholl LM (2017) Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer. JAMA Oncol 3(6):740–741. https://doi.org/10.1001/jamaoncol.2016.2835 CrossRefPubMed

36.

Ignatiadis M, Dawson SJ (2014) Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? Ann Oncol 25(12):2304–2313. https://doi.org/10.1093/annonc/mdu480 CrossRefPubMed

37.

Devonshire AS, Whale AS, Gutteridge A, Jones G, Cowen S, Foy CA et al (2014) Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Anal Bioanal Chem 406(26):6499–6512. https://doi.org/10.1007/s00216-014-7835-3 CrossRefPubMedPubMedCentral

38.

Wong D, Moturi S, Angkachatchai V, Mueller R, DeSantis G, van den Boom D et al (2013) Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. Clin Biochem 46(12):1099–1104. https://doi.org/10.1016/j.clinbiochem.2013.04.023 CrossRefPubMed

39.

Hidestrand M, Stokowski R, Song K, Oliphant A, Deavers J, Goetsch M et al (2012) Influence of temperature during transportation on cell-free DNA analysis. Fetal Diagn Ther 31(2):122–128. https://doi.org/10.1159/000335020 CrossRefPubMed

40.

Callari M, Tiberio P, De Cecco L, Cavadini E, Dugo M, Ghimenti C et al (2013) Feasibility of circulating miRNA microarray analysis from archival plasma samples. Anal Biochem 437(2):123–125. https://doi.org/10.1016/j.ab.2013.03.002 CrossRefPubMed

41.

Spornraft M, Kirchner B, Haase B, Benes V, Pfaffl MW, Riedmaier I (2014) Optimization of extraction of circulating RNAs from plasma--enabling small RNA sequencing. PLoS One 9(9):e107259. https://doi.org/10.1371/journal.pone.0107259 CrossRefPubMedPubMedCentral

42.

Sourvinou IS, Markou A, Lianidou ES (2013) Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn: JMD 15(6):827–834. https://doi.org/10.1016/j.jmoldx.2013.07.005 CrossRefPubMed

43.

Baranyai T, Herczeg K, Onodi Z, Voszka I, Modos K, Marton N et al (2015) Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods. PLoS One 10(12):e0145686. https://doi.org/10.1371/journal.pone.0145686 CrossRefPubMedPubMedCentral

44.

Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL (2005) Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11(3):1010–1020PubMed

45.

Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F et al (2015) RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell 28(5):666–676. https://doi.org/10.1016/j.ccell.2015.09.018 CrossRefPubMedPubMedCentral

46.

Aibaidula A, Lu JF, Wu JS, Zou HJ, Chen H, Wang YQ et al (2015) Establishment and maintenance of a standardized glioma tissue bank: Huashan experience. Cell Tissue Bank 16(2):271–281. https://doi.org/10.1007/s10561-014-9459-4 CrossRefPubMed

47.

Wang Z, Lebron JA, Wolf JJ (2015) Reliable quantification of mRNA in archived formalin-fixed tissue with or without paraffin embedding. J Pharmacol Toxicol Methods 71:103–109. https://doi.org/10.1016/j.vascn.2014.09.007 CrossRefPubMed

48.

Schweiger MR, Kerick M, Timmermann B, Albrecht MW, Borodina T, Parkhomchuk D et al (2009) Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One 4(5):e5548. https://doi.org/10.1371/journal.pone.0005548 CrossRefPubMedPubMedCentral

49.

Hedegaard J, Thorsen K, Lund MK, Hein AM, Hamilton-Dutoit SJ, Vang S et al (2014) Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PLoS One 9(5):e98187. https://doi.org/10.1371/journal.pone.0098187 CrossRefPubMedPubMedCentral

50.

Florell SR, Coffin CM, Holden JA, Zimmermann JW, Gerwels JW, Summers BK et al (2001) Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Modern pathology : an official journal of the United States and Canadian Academy of Pathology. Inc 14(2):116–128. https://doi.org/10.1038/modpathol.3880267 CrossRef

51.

Langdon SP (2004) Cancer Cell Culture. Methods in Molecular Medicine, vol 88. Humana Press. https://doi.org/10.1385/1592594069

52.

Mitra A, Mishra L, Li S (2013) Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol 31(6):347–354. https://doi.org/10.1016/j.tibtech.2013.03.006 CrossRefPubMedPubMedCentral

53.

Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL et al (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro-Oncology 7(2):164–176. https://doi.org/10.1215/s1152851704000821 CrossRefPubMedPubMedCentral

54.

Perskvist N, Norman I, Eklund C, Litton JE, Dillner J (2013) The Swedish cervical cytology biobank: sample handling and storage process. Biopreserv Biobank 11(1):19–24. https://doi.org/10.1089/bio.2012.0036 CrossRefPubMed

55.

Elliott P, Peakman TC (2008) The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 37(2):234–244. https://doi.org/10.1093/ije/dym276 CrossRefPubMed

56.

Witon M, Strapagiel D, Glenska-Olender J, Chroscicka A, Ferdyn K, Skokowski J et al (2017) Organization of BBMRI.pl: The Polish Biobanking Network. Biopreserv Biobank 15(3):264–269. https://doi.org/10.1089/bio.2016.0091 CrossRefPubMed

57.

Vested A, Ramlau-Hansen CH, Olsen SF, Bonde JP, Kristensen SL, Halldorsson TI et al (2013) Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men. Environ Health Perspect 121(4):453–458. https://doi.org/10.1289/ehp.1205118 PubMedPubMedCentralCrossRef

58.

Lee JE, Kim JH, Hong EJ, Yoo HS, Nam HY, Park O (2012) National Biobank of Korea: Quality control Programs of Collected-human Biospecimens. Osong Public Health Res Perspect 3(3):185–189. https://doi.org/10.1016/j.phrp.2012.07.007 CrossRefPubMedPubMedCentral

59.

Mathay C, Hamot G, Henry E, Georges L, Bellora C, Lebrun L et al (2015) Method optimization for fecal sample collection and fecal DNA extraction. Biopreserv Biobank 13(2):79–93. https://doi.org/10.1089/bio.2014.0031 CrossRefPubMed

60.

Podzimek S, Vondrackova L, Duskova J, Janatova T, Broukal Z (2016) Salivary Markers for Periodontal and General Diseases. Dis Markers 2016:9179632. https://doi.org/10.1155/2016/9179632 CrossRefPubMedPubMedCentral

61.

Eglash A (2010) ABM clinical protocol #8: human milk storage information for home use for full-term infants (original protocol March 2004; revision #1 March 2010). Breastfeed Med 5(3):127–130. https://doi.org/10.1089/bfm.2010.9988 CrossRefPubMed

62.

2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories (2012) Biopreserv Biobank 10(2):79–161. https://doi.org/10.1089/bio.2012.1022 CrossRef

63.

He K (2011) Trace elements in nails as biomarkers in clinical research. Eur J Clin Investig 41(1):98–102. https://doi.org/10.1111/j.1365-2362.2010.02373.x CrossRef

64.

Liu LY, He K, Hites RA, Salamova A (2016) Hair and Nails as Noninvasive Biomarkers of Human Exposure to Brominated and Organophosphate Flame Retardants. Environ Sci Technol 50(6):3065–3073. https://doi.org/10.1021/acs.est.5b05073 CrossRefPubMed

65.

Willemse EA, Koel-Simmelink MJ, Durieux-Lu S, van der Flier WM, Teunissen CE (2015) Standard biobanking conditions prevent evaporation of body fluid samples. Clin Chim Acta 442:141–145. https://doi.org/10.1016/j.cca.2015.01.036 CrossRefPubMed

66.

Kofanova OA, Mommaerts K, Betsou F (2015) Tube Polypropylene: A Neglected Critical Parameter for Protein Adsorption During Biospecimen Storage. Biopreserv Biobank 13(4):296–298. https://doi.org/10.1089/bio.2014.0082 CrossRefPubMed

67.

Malm J, Lindberg H, Erlinge D, Appelqvist R, Yakovleva M, Welinder C et al (2015) Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies. Clin Transl Med 4(1):67. https://doi.org/10.1186/s40169-015-0067-0 CrossRefPubMed

68.

Nussbeck SY, Skrowny D, O'Donoghue S, Schulze TG, Helbing K (2014) How to Design Biospecimen Identifiers and Integrate Relevant Functionalities into Your Biospecimen Management System. Biopreserv Biobank 12(3):199–205. https://doi.org/10.1089/bio.2013.0085 CrossRefPubMedPubMedCentral

69.

Riondino S (2015) Sample PReanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols. J Biorepository Sci Appl Med 3:15–21

70.

Artene SA, Ciurea ME, Purcaru SO, Tache DE, Tataranu LG, Lupu M et al (2013) Biobanking in a constantly developing medical world. TheScientificWorldJOURNAL 2013:343275. https://doi.org/10.1155/2013/343275 CrossRefPubMedPubMedCentral

71.

Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D et al (2010) Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomark Prev 19(4):1004–1011. https://doi.org/10.1158/1055-9965.EPI-09-1268 CrossRef

72.

Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R et al (2011) Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119(2):92–101. https://doi.org/10.1002/cncy.20147 CrossRefPubMed

73.

Merino-Martinez R, Norlin L, van Enckevort D, Anton G, Schuffenhauer S, Silander K et al (2016) Toward Global Biobank Integration by Implementation of the Minimum Information About BIobank Data Sharing (MIABIS 2.0 Core). Biopreserv Biobank 14(4):298–306. https://doi.org/10.1089/bio.2015.0070 CrossRefPubMed

74.

Zika E, Paci D, Braun A, Rijkers-Defrasne S, Deschenes M, Fortier I et al (2011) A European survey on biobanks: trends and issues. Public Health Genomics 14(2):96–103. https://doi.org/10.1159/000296278 CrossRefPubMed

75.

Izzo M, Mortola F, Arnulfo G, Fato MM, Varesio L (2014) A digital repository with an extensible data model for biobanking and genomic analysis management. BMC Genomics 15(Suppl 3):S3. https://doi.org/10.1186/1471-2164-15-s3-s3 CrossRefPubMedPubMedCentral

76.

Sariyar M, Schluender I, Smee C, Suhr S (2015) Sharing and Reuse of Sensitive Data and Samples: Supporting Researchers in Identifying Ethical and Legal Requirements. Biopreserv Biobank 13(4):263–270. https://doi.org/10.1089/bio.2015.0014 CrossRefPubMedPubMedCentral

77.

Tebbakha R (2013) Biobank–Short Message Service for Linking Patients and Samples. Telemed e-Health 19(9):717–721. https://doi.org/10.1089/tmj.2012.0231 CrossRef

78.

Ravid R (2008) Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing? Cell Tissue Bank 9(2):121–137. https://doi.org/10.1007/s10561-007-9055-y CrossRefPubMed

79.

Steinsbekk KS, Kare Myskja B, Solberg B (2013) Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem? Eur J Hum Gen: EJHG 21(9):897–902. https://doi.org/10.1038/ejhg.2012.282 CrossRef

80.

Colledge F, Persson K, Elger B, Shaw D (2014) Sample and data sharing barriers in biobanking: consent, committees, and compromises. Ann Diagn Pathol 18(2):78–81. https://doi.org/10.1016/j.anndiagpath.2013.12.002 CrossRefPubMed

81.

Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW et al (2008) Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 36(2):219–248, 211. https://doi.org/10.1111/j.1748-720X.2008.00266.x CrossRefPubMedPubMedCentral

82.

Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM et al (2012) Managing Incidental Findings and Research Results in Genomic Research Involving Biobanks & Archived Datasets. Genet Med 14(4):361–384. https://doi.org/10.1038/gim.2012.23 CrossRefPubMedPubMedCentral

83.

Fleming J, Critchley C, Otlowski M, Stewart C, Kerridge I (2015) Attitudes of the general public towards the disclosure of individual research results and incidental findings from biobank genomic research in Australia. Intern Med J 45(12):1274–1279. https://doi.org/10.1111/imj.12911 CrossRefPubMed

84.

Giesbertz NA, Bredenoord AL, van Delden JJ (2015) Consent procedures in pediatric biobanks. Eur J Hum Gen: EJHG 23 (9):1129–1134. https://doi.org/10.1038/ejhg.2014.267

85.

Rush A, Battisti R, Barton B, Catchpoole D (2015) Opinions of Young Adults on Re-Consenting for Biobanking. J Pediatr 167(4):925–930. https://doi.org/10.1016/j.jpeds.2015.07.005 CrossRefPubMed

86.

Virani AH, Longstaff H (2014) Ethical Considerations in Biobanks: How a Public Health Ethics Perspective Sheds New Light on Old Controversies. J Genet Couns. https://doi.org/10.1007/s10897-014-9781-9

87.

Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE (2013) Neglected ethical issues in biobank management: Results from a U.S. study. Life Sci Soc Policy 9(1):1. https://doi.org/10.1186/2195-7819-9-1 CrossRefPubMedPubMedCentral

88.

Melas PA, Sjoholm LK, Forsner T, Edhborg M, Juth N, Forsell Y et al (2010) Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 36(2):93–98. https://doi.org/10.1136/jme.2009.032367 CrossRefPubMed

89.

Pereira S, Gibbs RA, McGuire AL (2014) Open Access Data Sharing in Genomic Research. Gene 5(3):739–747. https://doi.org/10.3390/genes5030739 CrossRef

90.

Hood L (2013) Systems biology and p4 medicine: past, present, and future. Rambam Maimonides Med J 4(2):e0012. https://doi.org/10.5041/RMMJ.10112 CrossRefPubMedPubMedCentral

91.

Kreiner T, Irion S (2013) Whole-genome analysis, stem cell research, and the future of biobanks. Cell Stem Cell 12(5):513–516. https://doi.org/10.1016/j.stem.2013.04.024 CrossRefPubMed

92.

Gelpi E, van der Zee J, Turon Estrada A, Van Broeckhoven C, Sanchez-Valle R (2014) TARDBP mutation p.Ile383Val associated with semantic dementia and complex proteinopathy. Neuropathol Appl Neurobiol 40(2):225–230. https://doi.org/10.1111/nan.12063 CrossRefPubMed

93.

Koszarska M, Kucsma N, Kiss K, Varady G, Gera M, Antalffy G et al (2014) Screening the Expression of ABCB6 in Erythrocytes Reveals an Unexpectedly High Frequency of Lan Mutations in Healthy Individuals. PLoS One 9(10):e111590. https://doi.org/10.1371/journal.pone.0111590 CrossRefPubMedPubMedCentral

94.

Jenkinson C, Elliott V, Menon U, Apostolidou S, Fourkala OE, Gentry-Maharaj A et al (2014) Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteome 113c:400–402. https://doi.org/10.1016/j.jprot.2014.10.001 CrossRef

95.

Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK et al (2015) Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk. Cancer Epidemiol Biomark Prev 24(11):1680–1691. https://doi.org/10.1158/1055-9965.epi-15-0363 CrossRef

96.

Kvistad SS, Myhr KM, Holmoy T, Saltyte Benth J, Wergeland S, Beiske AG et al (2015) Body mass index influence interferon-beta treatment response in multiple sclerosis. J Neuroimmunol 288:92–97. https://doi.org/10.1016/j.jneuroim.2015.09.008 CrossRefPubMed

97.

Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, Chu AY et al (2015) Genome-wide Association Studies Identify Genetic Loci Associated with Albuminuria in Diabetes. Diabetes. https://doi.org/10.2337/db15-1313

98.

Westerlind H, Mellander MR, Bresso F, Munch A, Bonfiglio F, Assadi G et al (2015) Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis. Gut. https://doi.org/10.1136/gutjnl-2015-309934

99.

Wakuda K, Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi S et al (2014) Molecular profiling of small cell lung cancer in a Japanese cohort. Lung Cancer (Amst, Netherlands) 84(2):139–144. https://doi.org/10.1016/j.lungcan.2014.02.013 CrossRef

100.

Allegra M, Giacchero D, Segalen C, Dumaz N, Butori C, Hofman V et al (2014) A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib. J Investig Dermatol 134(5):1473–1476. https://doi.org/10.1038/jid.2013.525 CrossRefPubMed

101.

Esplin ED, Oei L, Snyder MP (2014) Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease. Pharmacogenomics 15(14):1771–1790. https://doi.org/10.2217/pgs.14.117 CrossRefPubMedPubMedCentral

102.

Lisanti MP, Tanowitz HB (2012) Translational discoveries, personalized medicine, and living biobanks of the future. Am J Pathol 180(4):1334–1336. https://doi.org/10.1016/j.ajpath.2012.02.003 CrossRefPubMed

103.

van Ommen GJ, Tornwall O, Brechot C, Dagher G, Galli J, Hveem K et al (2014) BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres. Eur J Hum Gen: EJHG. https://doi.org/10.1038/ejhg.2014.235

104.

Womack C, Mager SR (2014) Human biological sample biobanking to support tissue biomarkers in pharmaceutical research and development. Methods (San Diego, Calif) 70(1):3–11. https://doi.org/10.1016/j.ymeth.2014.01.014 CrossRef

105.

Lu YC, Chang JT, Huang YC, Huang CC, Chen WH, Lee LY et al (2014) Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem. https://doi.org/10.1016/j.clinbiochem.2014.11.020

106.

Malaguarnera M, Uccello M, Bellanca S, La Rosa B, Vacante M, Cristaldi E et al (2014) Elevated chromogranin A serum levels in ovarian carcinoma patients. Indian J Cancer 51(3):315–318. https://doi.org/10.4103/0019-509x.146776 CrossRefPubMed

107.

Nagar S, Ahmed S, Peeples C, Urban N, Boura J, Thibodeau B et al (2014) Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms. Am J Surg 207(4):596–601. https://doi.org/10.1016/j.amjsurg.2013.06.012 CrossRefPubMed

108.

Letellier E, Schmitz M, Baig K, Beaume N, Schwartz C, Frasquilho S et al (2014) Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer 111(4):726–735. https://doi.org/10.1038/bjc.2014.377 CrossRefPubMedPubMedCentral

109.

Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ et al (2014) Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc 89(1):25–33. https://doi.org/10.1016/j.mayocp.2013.10.021 CrossRefPubMedPubMedCentral

110.

Almoguera B, Vazquez L, Connolly JJ, Bradfield J, Sleiman P, Keating B et al (2014) Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes. Front Genet 5:96. https://doi.org/10.3389/fgene.2014.00096 CrossRefPubMedPubMedCentral

111.

Kawai VK, Cunningham A, Vear SI, Van Driest SL, Oginni A, Xu H et al (2014) Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics 15(16):1973–1983. https://doi.org/10.2217/pgs.14.153 CrossRefPubMedPubMedCentral

112.

Henderson GE, Cadigan RJ, Edwards TP, Conlon I, Nelson AG, Evans JP et al (2013) Characterizing biobank organizations in the U.S.: results from a national survey. Genome Med 5(1):3. https://doi.org/10.1186/gm407 CrossRefPubMedPubMedCentral

Title: Aspects of Modern Biobank Activity – Comprehensive Review
Authors: Wiktor Paskal
Adriana M. Paskal
Tomasz Dębski
Maciej Gryziak
Janusz Jaworowski
Publication date: 01-10-2018
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2018
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-018-0418-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

The B7 Family Member B7-H6: a New Bane of Tumor

Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers

Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker

Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer

Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma

The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications

Keynote webinar | Spotlight on antibody–drug conjugates in cancer